Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
The New England Journal of Medicine
|
May 13, 2024
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Martin S Maron, Ahmad Masri, Michael E Nassif, et al.
Journal of the American College of Cardiology
|
September 11, 2025
Effect of Aficamten Compared With Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM
Sheila M Hegde, Xiaowen Wang, Pablo Garcia-Pavia, et al.
The New England Journal of Medicine
|
September 1, 2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
Pablo Garcia-Pavia, Martin S Maron, Ahmad Masri, et al.
Journal of the American College of Cardiology
|
December 5, 2025
Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial
Andrew Wang, Pablo Garcia-Pavia, Ahmad Masri, et al.
JAMA Cardiology
|
June 17, 2026
Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial
Gregory D Lewis, Pablo Garcia-Pavia, Ahmad Masri, et al.
Journal of the American Heart Association
|
July 26, 2024
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Caroline J Coats, Ahmad Masri, Michael E Nassif, et al.
Journal of the American College of Cardiology
|
January 6, 2026
Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy
Michael E Nassif, Pablo Garcia-Pavia, Ahmad Masri, et al.
Journal of the American College of Cardiology
|
October 1, 2024
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Martin S Maron, Ahmad Masri, Michael E Nassif, et al.
European Journal of Heart Failure
|
June 22, 2013
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document
Faiez Zannad, Angeles Alonso Garcia, Stefan D Anker, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
The New England Journal of Medicine
|
May 13, 2024
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Martin S Maron, Ahmad Masri, Michael E Nassif, et al.
Journal of the American College of Cardiology
|
September 11, 2025
Effect of Aficamten Compared With Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM
Sheila M Hegde, Xiaowen Wang, Pablo Garcia-Pavia, et al.
The New England Journal of Medicine
|
September 1, 2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
Pablo Garcia-Pavia, Martin S Maron, Ahmad Masri, et al.
Journal of the American College of Cardiology
|
December 5, 2025
Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial
Andrew Wang, Pablo Garcia-Pavia, Ahmad Masri, et al.
JAMA Cardiology
|
June 17, 2026
Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial
Gregory D Lewis, Pablo Garcia-Pavia, Ahmad Masri, et al.
Journal of the American Heart Association
|
July 26, 2024
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Caroline J Coats, Ahmad Masri, Michael E Nassif, et al.
Journal of the American College of Cardiology
|
January 6, 2026
Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy
Michael E Nassif, Pablo Garcia-Pavia, Ahmad Masri, et al.
Journal of the American College of Cardiology
|
October 1, 2024
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Martin S Maron, Ahmad Masri, Michael E Nassif, et al.
European Journal of Heart Failure
|
June 22, 2013
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document
Faiez Zannad, Angeles Alonso Garcia, Stefan D Anker, et al.
Page
of 10